Aurobindo’s Pediatric AIDS Combo Generic Approved; Eugia Restructuring Back On Cards

Anticipates Having Six To Seven Biosimilars In Regulated Markets By 2028

Growth Strategy
Aurobindo Has Multiple Growth Strategies Up Its Sleeves • Source: Shutterstock

More from Products

More from Generics Bulletin